Denali Therapeutics Inc. 4

Alexander O. Schuth, COFO and Secretary of Denali Therapeutics Inc., sold 2,857 shares of common stock at about $25.07 per share to cover taxes related to vested RSUs.

On August 11, 2026, Alexander O. Schuth, COFO and Secretary of Denali Therapeutics Inc., sold 2,857 shares of common stock at approximately $25.07 per share, for proceeds of about $71,600, in a transaction disclosed as being executed solely to satisfy tax obligations arising from the settlement of previously vested RSUs. Following this sale, he beneficially owns 281,763 shares directly and an additional 523,749 shares indirectly through The Schuth Family Trust, which together include 135,475 unvested RSUs and 1,792 shares acquired under the ESPP on June 1, 2026. Using the reported transaction price as a proxy for market value, his aggregate post-transaction holdings are valued at roughly $20.2 million, indicating that the sale represents only a small, tax-related portion of his overall equity stake.

Filing Facts

CIK

1714899

Ticker

DNLI

Form

4

Source Type

fda

Accession

0001724311-26-000013

Alert Tier

5